Global Brand Drugs Market Growth 2020-2025
According to this study, over the next five years the Brand Drugs market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Brand Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Brand Drugs market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Brand Drugs, covering the supply chain analysis, impact assessment to the Brand Drugs market size growth rate in several scenarios, and the measures to be undertaken by Brand Drugs companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Biopharmaceutical
Chemistry Medicine
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Amgen
Roche
Johnson & Johnson
Merck & Co. (MSD)
Sanofi
Gilead Sciences
Novartis
GlaxoSmithKline (GSK)
AbbVie
Novo Nordisk
Takeda
Allergan
AstraZeneca
Teva
Eli Lilly
Takeda
Bayer
Bristol-Myers Squibb
Boehringer Ingelheim
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Brand Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Brand Drugs market by identifying its various subsegments.
Focuses on the key global Brand Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Brand Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Brand Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Brand Drugs Consumption 2015-2025
2.1.2 Brand Drugs Consumption CAGR by Region
2.2 Brand Drugs Segment by Type
2.2.1 Biopharmaceutical
2.2.2 Chemistry Medicine
2.3 Brand Drugs Consumption by Type
2.3.1 Global Brand Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Brand Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Brand Drugs Sale Price by Type (2015-2020)
2.4 Brand Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Brand Drugs Consumption by Application
2.5.1 Global Brand Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Brand Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Brand Drugs Sale Price by Type (2015-2020)
3 Global Brand Drugs by Company
3.1 Global Brand Drugs Sales Market Share by Company
3.1.1 Global Brand Drugs Sales by Company (2018-2020)
3.1.2 Global Brand Drugs Sales Market Share by Company (2018-2020)
3.2 Global Brand Drugs Revenue Market Share by Company
3.2.1 Global Brand Drugs Revenue by Company (2018-2020)
3.2.2 Global Brand Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Brand Drugs Sale Price by Company
3.4 Global Brand Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Brand Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Brand Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Brand Drugs by Regions
4.1 Brand Drugs by Regions
4.2 Americas Brand Drugs Consumption Growth
4.3 APAC Brand Drugs Consumption Growth
4.4 Europe Brand Drugs Consumption Growth
4.5 Middle East & Africa Brand Drugs Consumption Growth
5 Americas
5.1 Americas Brand Drugs Consumption by Countries
5.1.1 Americas Brand Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Brand Drugs Value by Countries (2015-2020)
5.2 Americas Brand Drugs Consumption by Type
5.3 Americas Brand Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Brand Drugs Consumption by Regions
6.1.1 APAC Brand Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Brand Drugs Value by Regions (2015-2020)
6.2 APAC Brand Drugs Consumption by Type
6.3 APAC Brand Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Brand Drugs by Countries
7.1.1 Europe Brand Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Brand Drugs Value by Countries (2015-2020)
7.2 Europe Brand Drugs Consumption by Type
7.3 Europe Brand Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Brand Drugs by Countries
8.1.1 Middle East & Africa Brand Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Brand Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Brand Drugs Consumption by Type
8.3 Middle East & Africa Brand Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Brand Drugs Distributors
10.3 Brand Drugs Customer
11 Global Brand Drugs Market Forecast
11.1 Global Brand Drugs Consumption Forecast (2021-2025)
11.2 Global Brand Drugs Forecast by Regions
11.2.1 Global Brand Drugs Forecast by Regions (2021-2025)
11.2.2 Global Brand Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Brand Drugs Forecast by Type
11.8 Global Brand Drugs Forecast by Application
12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Information
12.1.2 Brand Drugs Product Offered
12.1.3 Pfizer Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Amgen
12.2.1 Company Information
12.2.2 Brand Drugs Product Offered
12.2.3 Amgen Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Amgen Latest Developments
12.3 Roche
12.3.1 Company Information
12.3.2 Brand Drugs Product Offered
12.3.3 Roche Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Roche Latest Developments
12.4 Johnson & Johnson
12.4.1 Company Information
12.4.2 Brand Drugs Product Offered
12.4.3 Johnson & Johnson Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Johnson & Johnson Latest Developments
12.5 Merck & Co. (MSD)
12.5.1 Company Information
12.5.2 Brand Drugs Product Offered
12.5.3 Merck & Co. (MSD) Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Merck & Co. (MSD) Latest Developments
12.6 Sanofi
12.6.1 Company Information
12.6.2 Brand Drugs Product Offered
12.6.3 Sanofi Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Sanofi Latest Developments
12.7 Gilead Sciences
12.7.1 Company Information
12.7.2 Brand Drugs Product Offered
12.7.3 Gilead Sciences Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Gilead Sciences Latest Developments
12.8 Novartis
12.8.1 Company Information
12.8.2 Brand Drugs Product Offered
12.8.3 Novartis Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Novartis Latest Developments
12.9 GlaxoSmithKline (GSK)
12.9.1 Company Information
12.9.2 Brand Drugs Product Offered
12.9.3 GlaxoSmithKline (GSK) Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 GlaxoSmithKline (GSK) Latest Developments
12.10 AbbVie
12.10.1 Company Information
12.10.2 Brand Drugs Product Offered
12.10.3 AbbVie Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 AbbVie Latest Developments
12.11 Novo Nordisk
12.11.1 Company Information
12.11.2 Brand Drugs Product Offered
12.11.3 Novo Nordisk Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Novo Nordisk Latest Developments
12.12 Takeda
12.12.1 Company Information
12.12.2 Brand Drugs Product Offered
12.12.3 Takeda Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Takeda Latest Developments
12.13 Allergan
12.13.1 Company Information
12.13.2 Brand Drugs Product Offered
12.13.3 Allergan Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Allergan Latest Developments
12.14 AstraZeneca
12.14.1 Company Information
12.14.2 Brand Drugs Product Offered
12.14.3 AstraZeneca Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 AstraZeneca Latest Developments
12.15 Teva
12.15.1 Company Information
12.15.2 Brand Drugs Product Offered
12.15.3 Teva Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Teva Latest Developments
12.16 Eli Lilly
12.16.1 Company Information
12.16.2 Brand Drugs Product Offered
12.16.3 Eli Lilly Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Eli Lilly Latest Developments
12.17 Takeda
12.17.1 Company Information
12.17.2 Brand Drugs Product Offered
12.17.3 Takeda Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Takeda Latest Developments
12.18 Bayer
12.18.1 Company Information
12.18.2 Brand Drugs Product Offered
12.18.3 Bayer Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Bayer Latest Developments
12.19 Bristol-Myers Squibb
12.19.1 Company Information
12.19.2 Brand Drugs Product Offered
12.19.3 Bristol-Myers Squibb Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Bristol-Myers Squibb Latest Developments
12.20 Boehringer Ingelheim
12.20.1 Company Information
12.20.2 Brand Drugs Product Offered
12.20.3 Boehringer Ingelheim Brand Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Boehringer Ingelheim Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Brand Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Biopharmaceutical
Table 5. Major Players of Chemistry Medicine
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Brand Drugs Consumption Market Share by Type (2015-2020)
Table 8. Global Brand Drugs Revenue by Type (2015-2020) ($ million)
Table 9. Global Brand Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Brand Drugs Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Brand Drugs Consumption Market Share by Application (2015-2020)
Table 13. Global Brand Drugs Value by Application (2015-2020)
Table 14. Global Brand Drugs Value Market Share by Application (2015-2020)
Table 15. Global Brand Drugs Sale Price by Application (2015-2020)
Table 16. Global Brand Drugs Sales by Company (2017-2019) (K Units)
Table 17. Global Brand Drugs Sales Market Share by Company (2017-2019)
Table 18. Global Brand Drugs Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Brand Drugs Revenue Market Share by Company (2017-2019)
Table 20. Global Brand Drugs Sale Price by Company (2017-2019)
Table 21. Global Brand Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Brand Drugs Products Offered
Table 23. Brand Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Brand Drugs Consumption by Regions 2015-2020 (K Units)
Table 25. Global Brand Drugs Consumption Market Share by Regions 2015-2020
Table 26. Global Brand Drugs Value by Regions 2015-2020 ($ Millions)
Table 27. Global Brand Drugs Value Market Share by Regions 2015-2020
Table 28. Americas Brand Drugs Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Brand Drugs Consumption Market Share by Countries (2015-2020)
Table 30. Americas Brand Drugs Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Brand Drugs Value Market Share by Countries (2015-2020)
Table 32. Americas Brand Drugs Consumption by Type (2015-2020) (K Units)
Table 33. Americas Brand Drugs Consumption Market Share by Type (2015-2020)
Table 34. Americas Brand Drugs Consumption by Application (2015-2020) (K Units)
Table 35. Americas Brand Drugs Consumption Market Share by Application (2015-2020)
Table 36. APAC Brand Drugs Consumption by Regions (2015-2020) (K Units)
Table 37. APAC Brand Drugs Consumption Market Share by Regions (2015-2020)
Table 38. APAC Brand Drugs Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Brand Drugs Value Market Share by Regions (2015-2020)
Table 40. APAC Brand Drugs Consumption by Type (2015-2020) (K Units)
Table 41. APAC Brand Drugs Consumption Market Share by Type (2015-2020)
Table 42. APAC Brand Drugs Consumption by Application (2015-2020) (K Units)
Table 43. APAC Brand Drugs Consumption Market Share by Application (2015-2020)
Table 44. Europe Brand Drugs Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Brand Drugs Consumption Market Share by Countries (2015-2020)
Table 46. Europe Brand Drugs Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Brand Drugs Value Market Share by Countries (2015-2020)
Table 48. Europe Brand Drugs Consumption by Type (2015-2020) (K Units)
Table 49. Europe Brand Drugs Consumption Market Share by Type (2015-2020)
Table 50. Europe Brand Drugs Consumption by Application (2015-2020) (K Units)
Table 51. Europe Brand Drugs Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Brand Drugs Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Brand Drugs Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Brand Drugs Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Brand Drugs Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Brand Drugs Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Brand Drugs Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Brand Drugs Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Brand Drugs Consumption Market Share by Application (2015-2020)
Table 60. Brand Drugs Distributors List
Table 61. Brand Drugs Customer List
Table 62. Global Brand Drugs Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Brand Drugs Consumption Market Forecast by Regions
Table 64. Global Brand Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Brand Drugs Value Market Share Forecast by Regions
Table 66. Global Brand Drugs Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Brand Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Brand Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Brand Drugs Value Market Share Forecast by Type (2021-2025)
Table 70. Global Brand Drugs Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Brand Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Brand Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Brand Drugs Value Market Share Forecast by Application (2021-2025)
Table 74. Pfizer Product Offered
Table 75. Pfizer Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Pfizer Basic Information, Company Total Revenue (in $ million), Brand Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Amgen Product Offered
Table 80. Amgen Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. Amgen Main Business
Table 82. Amgen Latest Developments
Table 83. Amgen Basic Information, Company Total Revenue (in $ million), Brand Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Roche Product Offered
Table 85. Roche Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. Roche Main Business
Table 87. Roche Latest Developments
Table 88. Roche Basic Information, Company Total Revenue (in $ million), Brand Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Johnson & Johnson Product Offered
Table 90. Johnson & Johnson Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Johnson & Johnson Main Business
Table 92. Johnson & Johnson Latest Developments
Table 93. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Brand Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck & Co. (MSD) Product Offered
Table 95. Merck & Co. (MSD) Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Merck & Co. (MSD) Main Business
Table 97. Merck & Co. (MSD) Latest Developments
Table 98. Merck & Co. (MSD) Basic Information, Company Total Revenue (in $ million), Brand Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Product Offered
Table 100. Sanofi Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. Sanofi Main Business
Table 102. Sanofi Latest Developments
Table 103. Sanofi Basic Information, Company Total Revenue (in $ million), Brand Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Gilead Sciences Product Offered
Table 105. Gilead Sciences Basic Information, Company Total Revenue (in $ million), Brand Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Gilead Sciences Main Business
Table 107. Gilead Sciences Latest Developments
Table 108. Gilead Sciences Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 109. Novartis Product Offered
Table 110. Novartis Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. Novartis Main Business
Table 112. Novartis Latest Developments
Table 113. Novartis Basic Information, Company Total Revenue (in $ million), Brand Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. GlaxoSmithKline (GSK) Product Offered
Table 115. GlaxoSmithKline (GSK) Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. GlaxoSmithKline (GSK) Main Business
Table 117. GlaxoSmithKline (GSK) Latest Developments
Table 118. GlaxoSmithKline (GSK) Basic Information, Company Total Revenue (in $ million), Brand Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. AbbVie Product Offered
Table 120. AbbVie Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 121. AbbVie Main Business
Table 122. AbbVie Latest Developments
Table 123. AbbVie Basic Information, Company Total Revenue (in $ million), Brand Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Novo Nordisk Product Offered
Table 125. Novo Nordisk Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 126. Novo Nordisk Main Business
Table 127. Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Novo Nordisk Latest Developments
Table 129. Takeda Product Offered
Table 130. Takeda Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 131. Takeda Main Business
Table 132. Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Takeda Latest Developments
Table 134. Allergan Product Offered
Table 135. Allergan Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 136. Allergan Main Business
Table 137. Allergan Latest Developments
Table 138. Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. AstraZeneca Product Offered
Table 140. AstraZeneca Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 141. AstraZeneca Main Business
Table 142. AstraZeneca Latest Developments
Table 143. AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. Teva Product Offered
Table 145. Teva Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 146. Teva Main Business
Table 147. Teva Latest Developments
Table 148. Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Eli Lilly Product Offered
Table 150. Eli Lilly Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 151. Eli Lilly Main Business
Table 152. Eli Lilly Latest Developments
Table 153. Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 154. Takeda Product Offered
Table 155. Takeda Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 156. Takeda Main Business
Table 157. Takeda Latest Developments
Table 158. Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 159. Bayer Product Offered
Table 160. Bayer Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 161. Bayer Main Business
Table 162. Bayer Latest Developments
Table 163. Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 164. Bristol-Myers Squibb Product Offered
Table 165. Bristol-Myers Squibb Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 166. Bristol-Myers Squibb Main Business
Table 167. Bristol-Myers Squibb Latest Developments
Table 168. Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 169. Boehringer Ingelheim Product Offered
Table 170. Boehringer Ingelheim Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 171. Boehringer Ingelheim Main Business
Table 172. Boehringer Ingelheim Latest Developments
Table 173. Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Brand Drugs
Figure 2. Brand Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Brand Drugs Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Brand Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Biopharmaceutical
Figure 7. Product Picture of Chemistry Medicine
Figure 8. Global Brand Drugs Consumption Market Share by Type (2015-2020)
Figure 9. Global Brand Drugs Value Market Share by Type (2015-2020)
Figure 10. Brand Drugs Consumed in Hospital
Figure 11. Global Brand Drugs Market: Hospital (2015-2020) (K Units)
Figure 12. Global Brand Drugs Market: Hospital (2015-2020) ($ Millions)
Figure 13. Brand Drugs Consumed in Clinic
Figure 14. Global Brand Drugs Market: Clinic (2015-2020) (K Units)
Figure 15. Global Brand Drugs Market: Clinic (2015-2020) ($ Millions)
Figure 16. Brand Drugs Consumed in Other
Figure 17. Global Brand Drugs Market: Other (2015-2020) (K Units)
Figure 18. Global Brand Drugs Market: Other (2015-2020) ($ Millions)
Figure 19. Global Brand Drugs Consumption Market Share by Application (2015-2020)
Figure 20. Global Brand Drugs Value Market Share by Application (2015-2020)
Figure 21. Global Brand Drugs Sales Market Share by Company in 2017
Figure 22. Global Brand Drugs Sales Market Share by Company in 2019
Figure 23. Global Brand Drugs Revenue Market Share by Company in 2017
Figure 24. Global Brand Drugs Revenue Market Share by Company in 2019
Figure 25. Global Brand Drugs Sale Price by Company in 2019
Figure 26. Global Brand Drugs Consumption Market Share by Regions 2015-2020
Figure 27. Global Brand Drugs Value Market Share by Regions 2015-2020
Figure 28. Americas Brand Drugs Consumption 2015-2020 (K Units)
Figure 29. Americas Brand Drugs Value 2015-2020 ($ Millions)
Figure 30. APAC Brand Drugs Consumption 2015-2020 (K Units)
Figure 31. APAC Brand Drugs Value 2015-2020 ($ Millions)
Figure 32. Europe Brand Drugs Consumption 2015-2020 (K Units)
Figure 33. Europe Brand Drugs Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Brand Drugs Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Brand Drugs Value 2015-2020 ($ Millions)
Figure 36. Americas Brand Drugs Consumption Market Share by Countries in 2019
Figure 37. Americas Brand Drugs Value Market Share by Countries in 2019
Figure 38. Americas Brand Drugs Consumption Market Share by Type in 2019
Figure 39. Americas Brand Drugs Consumption Market Share by Application in 2019
Figure 40. United States Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 41. United States Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Brand Drugs Consumption Market Share by Countries in 2019
Figure 47. APAC Brand Drugs Value Market Share by Regions in 2019
Figure 48. APAC Brand Drugs Consumption Market Share by Type in 2019
Figure 49. APAC Brand Drugs Consumption Market Share by Application in 2019
Figure 50. China Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 51. China Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 58. India Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 59. India Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Brand Drugs Consumption Market Share by Countries in 2019
Figure 63. Europe Brand Drugs Value Market Share by Countries in 2019
Figure 64. Europe Brand Drugs Consumption Market Share by Type in 2019
Figure 65. Europe Brand Drugs Consumption Market Share by Application in 2019
Figure 66. Germany Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 68. France Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 69. France Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 70. UK Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 71. UK Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Brand Drugs Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Brand Drugs Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Brand Drugs Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Brand Drugs Consumption Market Share by Application in 2019
Figure 80. Egypt Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Brand Drugs Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Brand Drugs Value Growth 2015-2020 ($ Millions)
Figure 90. Global Brand Drugs Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Brand Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Brand Drugs Consumption 2021-2025 (K Units)
Figure 93. Americas Brand Drugs Value 2021-2025 ($ Millions)
Figure 94. APAC Brand Drugs Consumption 2021-2025 (K Units)
Figure 95. APAC Brand Drugs Value 2021-2025 ($ Millions)
Figure 96. Europe Brand Drugs Consumption 2021-2025 (K Units)
Figure 97. Europe Brand Drugs Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Brand Drugs Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Brand Drugs Value 2021-2025 ($ Millions)
Figure 100. United States Brand Drugs Consumption 2021-2025 (K Units)
Figure 101. United States Brand Drugs Value 2021-2025 ($ Millions)
Figure 102. Canada Brand Drugs Consumption 2021-2025 (K Units)
Figure 103. Canada Brand Drugs Value 2021-2025 ($ Millions)
Figure 104. Mexico Brand Drugs Consumption 2021-2025 (K Units)
Figure 105. Mexico Brand Drugs Value 2021-2025 ($ Millions)
Figure 106. Brazil Brand Drugs Consumption 2021-2025 (K Units)
Figure 107. Brazil Brand Drugs Value 2021-2025 ($ Millions)
Figure 108. China Brand Drugs Consumption 2021-2025 (K Units)
Figure 109. China Brand Drugs Value 2021-2025 ($ Millions)
Figure 110. Japan Brand Drugs Consumption 2021-2025 (K Units)
Figure 111. Japan Brand Drugs Value 2021-2025 ($ Millions)
Figure 112. Korea Brand Drugs Consumption 2021-2025 (K Units)
Figure 113. Korea Brand Drugs Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Brand Drugs Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Brand Drugs Value 2021-2025 ($ Millions)
Figure 116. India Brand Drugs Consumption 2021-2025 (K Units)
Figure 117. India Brand Drugs Value 2021-2025 ($ Millions)
Figure 118. Australia Brand Drugs Consumption 2021-2025 (K Units)
Figure 119. Australia Brand Drugs Value 2021-2025 ($ Millions)
Figure 120. Germany Brand Drugs Consumption 2021-2025 (K Units)
Figure 121. Germany Brand Drugs Value 2021-2025 ($ Millions)
Figure 122. France Brand Drugs Consumption 2021-2025 (K Units)
Figure 123. France Brand Drugs Value 2021-2025 ($ Millions)
Figure 124. UK Brand Drugs Consumption 2021-2025 (K Units)
Figure 125. UK Brand Drugs Value 2021-2025 ($ Millions)
Figure 126. Italy Brand Drugs Consumption 2021-2025 (K Units)
Figure 127. Italy Brand Drugs Value 2021-2025 ($ Millions)
Figure 128. Russia Brand Drugs Consumption 2021-2025 (K Units)
Figure 129. Russia Brand Drugs Value 2021-2025 ($ Millions)
Figure 130. Spain Brand Drugs Consumption 2021-2025 (K Units)
Figure 131. Spain Brand Drugs Value 2021-2025 ($ Millions)
Figure 132. Egypt Brand Drugs Consumption 2021-2025 (K Units)
Figure 133. Egypt Brand Drugs Value 2021-2025 ($ Millions)
Figure 134. South Africa Brand Drugs Consumption 2021-2025 (K Units)
Figure 135. South Africa Brand Drugs Value 2021-2025 ($ Millions)
Figure 136. Israel Brand Drugs Consumption 2021-2025 (K Units)
Figure 137. Israel Brand Drugs Value 2021-2025 ($ Millions)
Figure 138. Turkey Brand Drugs Consumption 2021-2025 (K Units)
Figure 139. Turkey Brand Drugs Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Brand Drugs Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Brand Drugs Value 2021-2025 ($ Millions)
Figure 142. Pfizer Brand Drugs Market Share (2018-2020)
Figure 143. Amgen Brand Drugs Market Share (2018-2020)
Figure 144. Roche Brand Drugs Market Share (2018-2020)
Figure 145. Johnson & Johnson Brand Drugs Market Share (2018-2020)
Figure 146. Merck & Co. (MSD) Brand Drugs Market Share (2018-2020)
Figure 147. Sanofi Brand Drugs Market Share (2018-2020)
Figure 148. Gilead Sciences Brand Drugs Market Share (2018-2020)
Figure 149. Novartis Brand Drugs Market Share (2018-2020)
Figure 150. GlaxoSmithKline (GSK) Brand Drugs Market Share (2018-2020)
Figure 151. AbbVie Brand Drugs Market Share (2018-2020)
Figure 152. Novo Nordisk Brand Drugs Market Share (2018-2020)
Figure 153. Takeda Brand Drugs Market Share (2018-2020)
Figure 154. Allergan Brand Drugs Market Share (2018-2020)
Figure 155. AstraZeneca Brand Drugs Market Share (2018-2020)
Figure 156. Teva Brand Drugs Market Share (2018-2020)
Figure 157. Eli Lilly Brand Drugs Market Share (2018-2020)
Figure 158. Takeda Brand Drugs Market Share (2018-2020)
Figure 159. Bayer Brand Drugs Market Share (2018-2020)
Figure 160. Bristol-Myers Squibb Brand Drugs Market Share (2018-2020)
Figure 161. Boehringer Ingelheim Brand Drugs Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets